Express Pharma - Page 515 of 2244 - Express Pharma

Alembic Pharma gets USFDA nod for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%

NPPA caps trade margins at 30 per cent for 137 anti-cancer medicines

Panel Discussion: From Panjim to the World — Goa’s export playbook

Precious metal catalysis: How to make your formulation business more viable with the aid of your own API

Technology play in nutraceuticals: Idea to commercialisation

Panel Discussion : Next-gen oral dosage forms

Filtration in formulation development – Selection and validation

Bridging gaps in disease management: Adherence and acceptance

Advancements in oral dosage forms

Polymer solutions for drug product manufacturing process

In-vitro and in-vivo correlation: General considerations

Overview on new USP <382> and its impact on parenteral product packaging and delivery systems

Panel Discussion : Bridging gaps in disease management